Applied Genetic Technologies (AGTC) Tops Q2 EPS by 45c

Applied Genetic Technologies (NASDAQ: AGTC) reported Q2 EPS of ($0.23), $0.45 better than the analyst estimate of ($0.68). Revenue for the quarter came in at $5.9 million versus the consensus estimate of $2.64 million.

For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.

You May Also Be Interested In

• Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
• Avantor (AVTR) Tops Q1 EPS by 2c
• NOV Inc (NOV) Tops Q1 EPS by 3c; offers guidance